Cargando…
Early detection of cancer in the general population: a blinded case–control study of p53 autoantibodies in colorectal cancer
BACKGROUND: Recent reports from cancer screening trials in high-risk populations suggest that autoantibodies can be detected before clinical diagnosis. However, there is minimal data on the role of autoantibody signatures in cancer screening in the general population. METHODS: Informative p53 peptid...
Autores principales: | Pedersen, J W, Gentry-Maharaj, A, Fourkala, E-O, Dawnay, A, Burnell, M, Zaikin, A, Pedersen, A E, Jacobs, I, Menon, U, Wandall, H H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553520/ https://www.ncbi.nlm.nih.gov/pubmed/23169294 http://dx.doi.org/10.1038/bjc.2012.517 |
Ejemplares similares
-
Cancer-associated autoantibodies to MUC1 and MUC4—A blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening
por: Pedersen, Johannes W, et al.
Publicado: (2014) -
Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer
por: Burford, B, et al.
Publicado: (2013) -
Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples
por: Thomas, D S, et al.
Publicado: (2015) -
Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening
por: Fourkala, E O, et al.
Publicado: (2012) -
Serum oestrogen receptor α and β bioactivity are independently associated with breast cancer: a proof of principle study
por: Widschwendter, M, et al.
Publicado: (2009)